CME Group Inc.(CME) Stock Research - Grey Stern Research

CME Group Inc. (CME) Stock Analysis

$240.73 (2.17%)

CME Financial Performance


Use the table below to view CME Group Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $240.73 -
52 Week Low $190.70 -
52 Week High $241.50 -
Market Cap $86.7 Billion 4/7
Gross Margin 66% 4/7
Profit Margin 56% 1/7
EBITDA margin 62% 1/7
Q2 - 2024 Revenue $1.6 Billion 5/7
Q2 - 2024 Earnings $879.4 Million 2/7
Q2 - 2024 Free Cash Flow $0 Million 7/7
Trailing 4 Quarters Revenue $6.0 Billion 5/7
Trailing 4 Quarters Earnings $3.4 Billion 2/7
Quarterly Earnings Growth 17% 5/7
Annual Earnings Growth 10% 5/7
Quarterly Revenue Growth 18% 4/7
Annual Revenue Growth 12% 5/7
Cash On Hand $2.3 Billion 2/7
Short Term Debt $749.7 Million 3/7
Long Term Debt $2.7 Billion 6/7

CME Group Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare CME Group Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 25.51 7/7
PS 14.35 2/7
PB 3.07 6/7
PC 37.36 5/7
Liabilities to Equity 3.88 2/7
ROA 0.02 6/7
ROE 0.12 3/7
Current Ratio 1.26 5/7
Quick Ratio 0.02 5/7
Long Term Debt to Equity 0.09 6/7
Debt to Equity 0.12 6/7
Burn Rate -3.97 4/7
Cash to Cap 0.03 2/7
CCR 7/7
EV to EBITDA 89.56 5/7
EV to Revenue 14.54 2/7

Company Details

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CEO: Hon. Terrence Duffy

Website: https://www.cmegroup.com

Address: 20 S Wacker Dr Chicago, ILLINOIS

Exchange: NASDAQ Global Select

Industry: Financial Data & Stock Exchanges

CME Group Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to CME Group Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
MSCI Inc. MSCI $47.7 Billion
Intercontinental Exchange, Inc. ICE $89.7 Billion
Moody's Corporation MCO $89.5 Billion
S&P Global Inc. SPGI $160.8 Billion
Nasdaq, Inc. NDAQ $46.5 Billion
Morningstar, Inc. MORN $15.1 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CME Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 1.6 Billion $879.4 Million
Q2 2024 $ 1.5 Billion $872.1 Million
Q1 2024 $ 1.5 Billion $844.4 Million
Q4 2023 $ 1.4 Billion $804.3 Million
Q3 2023 $ 1.3 Billion $750.2 Million
Q2 2023 $ 1.4 Billion $777.6 Million
Q1 2023 $ 1.4 Billion $883.8 Million
Q4 2022 $ 1.2 Billion $637.9 Million

View All

CME Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $2.3 Billion $137.8 Billion $3.4 Billion $28.2 Billion
Q2 2024 $1.8 Billion $123.4 Billion $3.4 Billion $27.6 Billion
Q1 2024 $1.4 Billion $132.1 Billion $3.4 Billion $27.2 Billion
Q4 2023 $2.9 Billion $129.7 Billion $3.4 Billion $26.7 Billion
Q3 2023 $2.3 Billion $125.6 Billion $3.4 Billion $28.2 Billion
Q2 2023 $1.9 Billion $151.3 Billion $3.4 Billion $27.8 Billion
Q1 2023 $1.6 Billion $166.0 Billion $3.4 Billion $27.4 Billion
Q4 2022 $2.7 Billion $174.2 Billion $3.4 Billion $26.9 Billion

View All

CME Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 $758.7 Million -$18.2 Million $353.0 Million
Q1 2024 $872.9 Million -$19.8 Million $2.8 Billion
Q4 2023 $172.6 Million $0 $611.9 Million
Q3 2023 $750.2 Million $0 $750.2 Million
Q2 2023 $1.6 Billion $0 $1.6 Billion
Q1 2023 $887.2 Million -$15.2 Million -$8.3 Billion
Q4 2022 $957.1 Million -$24.4 Million -$4.1 Billion
Q3 2022 $699.1 Million $0 $0

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions